We are live on ! Find out more
Ingalls & Snyder

Ingalls & Snyder Portfolio holdings

AUM $3.91B Turnover 11.18%
1-Year Est. Return 60.54%
 

Ingalls & Snyder is an investment management firm founded in 1924 by Roscoe C. Ingalls and John T. Snyder. Custom portfolio management is the core of what it offers clients, alongside wealth planning and family office services. It also manages money for institutions such as foundations and corporate retirement plans.

This Fund
S&P 500
This Quarter Est. Return
+11.84%
1 Year Est. Return
+60.54%
3 Year Est. Return
+249.52%
5 Year Est. Return
+323.37%
10 Year Est. Return
+892.94%
AUM
$3.91B
AUM Growth
+$249M
Cap. Flow
-$66M
Cap. Flow %
-1.69%
Top 10 Hldgs %
49.77%
Holding
501
New
25
Increased
103
Reduced
200
Closed
31
Avg Time Held Equity + Options
6.2 years
Top 10 Avg Time Held Equity + Options
5.5 years
Top 20 Avg Time Held Equity + Options
4.4 years
Avg Time Held Equity only
6.4 years
Top 10 Avg Time Held Equity only
5.5 years
Top 20 Avg Time Held Equity only
4.4 years

Top Sells

Rank Stock Value
1
CORT icon
Corcept Therapeutics
CORT
+$28.7M
2
STRS icon
STRATUS PPTYS INC
STRS
+$25.8M
3
OMER icon
Omeros
OMER
+$8.54M
4
PBI icon
Pitney Bowes
PBI
+$4.54M
5
CRS icon
Carpenter Technology
CRS
+$3.21M

Sector Composition

Rank Sector Weight
1 Healthcare 29.95%
2 Technology 12.71%
3 Energy 11.38%
4 Materials 10.96%
5 Financials 9.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
FROG icon
201
JFrog
FROG
$14.2B
$1.32M 0.03%
13,558
-17,420
-56% -$1.56M
2021 Q1
22 quarters
ALSN icon
202
Allison Transmission
ALSN
$10.4B
$1.31M 0.03%
11,576
-136
-1% -$16.4K
2018 Q1
34 quarters
LITE icon
203
Lumentum
LITE
$54.1B
$1.3M 0.03%
1,340
+93
+7% +$78.6K
2026 Q2
1 quarter
STX icon
204
Seagate
STX
$121B
$1.3M 0.03%
1,405
– –
2025 Q3
4 quarters
BCX icon
205
BlackRock Resources & Commodities Strategy Trust
BCX
$893M
$1.29M 0.03%
108,650
+2,800
+3% +$34.4K
2021 Q2
21 quarters
TRP icon
206
TC Energy
TRP
$67.5B
$1.26M 0.03%
21,741
+300
+1% +$19.3K
2019 Q1
30 quarters
CVX icon
207
PUT
Chevron
CVX
$429B
$1.25M 0.03%
+6,100
New +$1.2M
2026 Q3
0 quarters
ASML icon
208
ASML
ASML
$576B
$1.24M 0.03%
686
– –
2022 Q2
17 quarters
CVS icon
209
CVS Health
CVS
$114B
$1.24M 0.03%
14,483
-110
-0.8% -$10.8K
2013 Q4
51 quarters
FDX icon
210
FedEx
FDX
$75.9B
$1.23M 0.03%
4,303
-269
-6% -$84.5K
2015 Q4
43 quarters
VHT icon
211
Vanguard Health Care ETF
VHT
$21.1B
$1.22M 0.03%
3,854
-80
-2% -$25.1K
2020 Q1
26 quarters
YELP icon
212
Yelp
YELP
$1.11B
$1.2M 0.03%
65,119
-3,863
-6% -$90.8K
2016 Q4
39 quarters
IRM icon
213
Iron Mountain
IRM
$33.9B
$1.19M 0.03%
10,715
-10
-0.1% -$1.2K
2013 Q2
53 quarters
PM icon
214
Philip Morris
PM
$310B
$1.17M 0.03%
6,124
– –
2013 Q2
53 quarters
SGOL icon
215
abrdn Physical Gold Shares ETF
SGOL
$6.48B
$1.16M 0.03%
29,340
– –
2020 Q4
23 quarters
CRM icon
216
Salesforce
CRM
$179B
$1.15M 0.03%
5,023
-168
-3% -$34.7K
2018 Q2
33 quarters
FURY icon
217
Fury Gold Mines
FURY
$89.4M
$1.13M 0.03%
2,135,125
– –
2017 Q3
36 quarters
PLTR icon
218
Palantir
PLTR
$405B
$1.11M 0.03%
5,944
– –
2024 Q4
7 quarters
IONQ icon
219
IonQ
IONQ
$13.4B
$1.11M 0.03%
25,250
+625
+3% +$25.3K
2025 Q3
4 quarters
NVO icon
220
Novo Nordisk
NVO
$184B
$1.1M 0.03%
29,042
+225
+0.8% +$10.4K
2018 Q3
32 quarters
ZION icon
221
Zions Bancorporation
ZION
$9.6B
$1.1M 0.03%
17,545
+10,589
+152% +$727K
2023 Q3
12 quarters
RPM icon
222
RPM International
RPM
$13.2B
$1.07M 0.03%
10,815
– –
2013 Q2
53 quarters
SPGI icon
223
S&P Global
SPGI
$137B
$1.06M 0.03%
2,698
– –
2016 Q3
40 quarters
UNH icon
224
UnitedHealth
UNH
$365B
$1.04M 0.03%
2,837
-108
-4% -$43.5K
2016 Q3
40 quarters
GXO icon
225
GXO Logistics
GXO
$6.17B
$1.03M 0.03%
23,193
+15,542
+203% +$755K
2026 Q1
2 quarters

Similar funds

Ingalls & Snyder's Q3 2026 Portfolio in Review

As of Q3 2026, Ingalls & Snyder held 501 positions worth $3.91B, up 6.8% from $3.66B the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Ingalls & Snyder's Q3 2026 filing shows 25 new, 103 increased, 200 reduced and 31 closed positions. Its largest new stake was Howmet Aerospace: 6,486 shares worth $1.47M. The largest sale was Corcept Therapeutics, an estimated $28.7M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 26% a quarter earlier, followed by Technology and Energy.

  • Ingalls & Snyder's largest Q3 2026 buy was Howmet Aerospace: 6,486 shares worth $1.47M.
  • Ingalls & Snyder added most to State Street SPDR S&P 500 ETF Trust in Q3 2026, an estimated $11.5M increase.
  • Ingalls & Snyder's biggest Q3 2026 reduction was Corcept Therapeutics, cutting an estimated $28.7M.
  • Ingalls & Snyder fully exited STRATUS PPTYS INC in Q3 2026, selling an estimated $25.8M.
  • Ingalls & Snyder's ten largest holdings make up 50% of its $3.91B portfolio in Q3 2026.
  • Ingalls & Snyder opened 25 new positions and closed 31 in Q3 2026.
  • Ingalls & Snyder's portfolio value rose 6.8% quarter-over-quarter to $3.91B.

Based on Ingalls & Snyder's 13F filing for Q3 2026, filed 12 Nov 2026.